These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor. Bharadwaj AG; Kempster E; Waisman DM Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416 [TBL] [Abstract][Full Text] [Related]
5. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. Madureira PA; O'Connell PA; Surette AP; Miller VA; Waisman DM J Biomed Biotechnol; 2012; 2012():353687. PubMed ID: 23118506 [TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. Zhang L; Fogg DK; Waisman DM J Biol Chem; 2004 Jan; 279(3):2053-62. PubMed ID: 14570893 [TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. Zhang Y; Zhou ZH; Bugge TH; Wahl LM J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546 [TBL] [Abstract][Full Text] [Related]
8. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. MacLeod TJ; Kwon M; Filipenko NR; Waisman DM J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231 [TBL] [Abstract][Full Text] [Related]
9. Regulation of fibrinolysis by S100A10 in vivo. Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297 [TBL] [Abstract][Full Text] [Related]
10. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins. Bharadwaj A; Kempster E; Waisman DM Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495 [TBL] [Abstract][Full Text] [Related]
11. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity. Bydoun M; Waisman DM Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855 [TBL] [Abstract][Full Text] [Related]
12. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. Zhang J; Guo B; Zhang Y; Cao J; Chen T Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413 [TBL] [Abstract][Full Text] [Related]
13. Regulation of S100A10 by the PML-RAR-α oncoprotein. O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922 [TBL] [Abstract][Full Text] [Related]
14. Multiple functions of S100A10, an important cancer promoter. Saiki Y; Horii A Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598 [TBL] [Abstract][Full Text] [Related]
15. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427 [TBL] [Abstract][Full Text] [Related]
17. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells. Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216 [TBL] [Abstract][Full Text] [Related]
18. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer. Noye TM; Lokman NA; Oehler MK; Ricciardelli C Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling. Stewart AG; Xia YC; Harris T; Royce S; Hamilton JA; Schuliga M Br J Pharmacol; 2013 Dec; 170(7):1421-35. PubMed ID: 24111848 [TBL] [Abstract][Full Text] [Related]
20. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]